The collaboration with the FDA Office of Applied Research and Safety Assessment will focus inaugural projects on Shiga-toxin producing E. coli, Cyclospora cayetanensis, Salmonella spp. and Listeria monocytogenes CHICAGO, Feb. 28, 2024 /PRNewswire/ — bioMérieux, a world leader in in vitro…
bioMérieux and the Food and Drug Administration Launch Research Collaboration to Improve Microbial Detection Tools to Combat Food-Borne Pathogens
This post was originally published on this site